As expected, the obtained UCNPs@PDL nanoprobe would carry DNA nanotrains to selectively target cancer cells and then locate in the nucleus where the anti-PCNA aptamer would specially bind with PCNA to induce the in situ release of DOX molecules. This evidence concerns the gene PCNA and cancer.